RUBIN MEDICAL ApS: Financial statements 2012
CVR: 31768608
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
RUBIN MEDICAL ApS (CVR 31768608) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 9,428,712 and a net result of DKK -6,377. The profit margin was -0.1%. Equity in the 2012 report amounted to DKK 715,145. The solvency ratio was 17%.
- Revenue
- DKK 9,428,712
- Gross Profit
- DKK 1,687,781
- Profit/Loss
- DKK -6,377
- Equity
- DKK 715,145
- Total Assets
- DKK 4,212,446
Official annual report
Keep an eye on RUBIN MEDICAL ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of October 31, 2012, Karl-Johan Öhman has joined the board of directors of RUBIN MEDICAL ApS.
As of October 31, 2012, Christel Martin Persson has joined the board of directors of RUBIN MEDICAL ApS.
As of October 31, 2012, Carl Johan Stefan Helgesson has joined the board of directors of RUBIN MEDICAL ApS.
As of October 31, 2012, Finn Arne Nielsen has left the board of directors of RUBIN MEDICAL ApS.
As of October 31, 2012, Michael Cederhag has left the board of directors of RUBIN MEDICAL ApS.
As of October 31, 2012, Ina Nissen has left the board of directors of RUBIN MEDICAL ApS.
As of October 31, 2012, Karl-Johan Öhman is registered as director of RUBIN MEDICAL ApS.
As of October 31, 2012, Michael Cederhag has stepped down as adm. dir. of RUBIN MEDICAL ApS.
About RUBIN MEDICAL ApS
RUBIN MEDICAL ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2008. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Ulrika Fröbel. The board consists of Ulrika Fröbel (chair), Christel Martin Persson and Karl-Johan Öhman. The company is owned by Rubin Medical AB. The company has 7 employees (2026). In 2025, the company reported a gross profit of DKK 60,802,023 and a net result of DKK 42,578,566 compared with DKK 45,329,373 the year before. Equity in the 2025 report amounted to DKK 71,053,463.